WallStreetZenWallStreetZen

NASDAQ: NKTR
Nektar Therapeutics Stock Ownership - Who owns Nektar Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Nektar Therapeutics insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Howard W. RobinPresident CEO2025-09-091,210$48.18
$58.30kSell
Howard W. RobinPresident CEO2025-09-092,156$47.49
$102.39kSell
Howard W. RobinPresident CEO2025-09-091,200$46.41
$55.69kSell
Howard W. RobinPresident CEO2025-09-092,100$45.16
$94.84kSell
Howard W. RobinPresident CEO2025-09-053,304$37.87
$125.12kSell
Howard W. RobinPresident CEO2025-09-051,136$39.89
$45.32kSell
Howard W. RobinPresident CEO2025-09-052,226$38.82
$86.41kSell
Jonathan ZalevskyChief RD Officer2025-09-04307$35.69
$10.96kSell
Howard W. RobinPresident CEO2025-09-041,923$32.37
$62.25kSell
Howard W. RobinPresident CEO2025-09-041,496$33.54
$50.18kSell

1 of 4

NKTR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NKTR insiders and whales buy or sell their stock.

NKTR Shareholders

What type of owners hold Nektar Therapeutics stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Deep Track Capital LP147.85%18,344,000$1.09BInsider
John Stuart Patton24.06%2,984,703$177.98MInsider
Vanguard Group Inc5.88%729,492$43.50MInstitution
Nantahala Capital Management LLC5.72%709,761$42.32MInstitution
Millennium Management LLC5.23%649,033$38.70MInstitution
Ajit Gill4.66%578,645$34.50MInsider
Aqr Capital Management LLC3.45%427,867$25.51MInstitution
Acadian Asset Management LLC3.39%420,958$25.10MInstitution
Blackrock Inc3.35%415,226$24.76MInstitution
Balyasny Asset Management LP3.11%386,290$23.03MInstitution

1 of 3

NKTR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NKTR23.75%76.25%Net SellingNet Selling
YDES0.00%3.67%
GHRS70.22%0.00%
CRMD50.35%10.12%Net SellingNet Buying
REPL66.02%33.98%Net SellingNet Selling
View Top Biotech Stocks

Nektar Therapeutics Stock Ownership FAQ

Who owns Nektar Therapeutics?

Nektar Therapeutics (NASDAQ: NKTR) is owned by 61.77% institutional shareholders, 198.36% Nektar Therapeutics insiders, and 0.00% retail investors. Deep Track Capital LP is the largest individual Nektar Therapeutics shareholder, owning 18.34M shares representing 147.85% of the company. Deep Track Capital LP's Nektar Therapeutics shares are currently valued at $1.15B.

If you're new to stock investing, here's how to buy Nektar Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.